QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=61D0838D45F2925C0D585C1866D267A3;jsessionid=A3C2B7747C0EC2BE7C7EA742CAAAB0BE;jsessionid=5F2C9105D7F968E72E4FA18353A91871;jsessionid=56E7DB1732EBFF5174F675EDFE5C1990 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=61D0838D45F2925C0D585C1866D267A3;jsessionid=A3C2B7747C0EC2BE7C7EA742CAAAB0BE;jsessionid=5F2C9105D7F968E72E4FA18353A91871;jsessionid=56E7DB1732EBFF5174F675EDFE5C1990